Skip to main content

India–Pakistan Trade: A Case Study of the Pharmaceutical Sector

  • Chapter
  • First Online:
India-Pakistan Trade Normalisation

Abstract

This paper attempts to evaluate the possible gains and losses arising from the gradual opening up of pharmaceutical trade between India and Pakistan. We explain the comparative advantages of both countries at a disaggregated level, followed by a qualitative analysis of various perceptions and experiences of Pakistan’s pharmaceutical manufacturers with respect to trade with India. We find that a gradual opening up of pharmaceutical trade with India may allow Pakistan to enhance the quality of locally produced medicines through raw material, intermediate inputs, knowledge, and skills transfer from India. Pakistan, in the medium to long run, may also be able to diversify its pharmaceutical export base, reduce cost of production and achieve higher competitiveness through the development of value chain linkages with India. Such linkages are important to cater to the projected rise in demand for pharmaceuticals in Pakistan, Afghanistan and abroad.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The statistics here pertain to Chap. 30, i.e. pharmaceutical products, only.

  2. 2.

    All these products are listed at the 8-digit level.

  3. 3.

    Leading consumer groups from Islamabad and Karachi participated in our focus group discussion.

  4. 4.

    The organisation does not even have a website.

Abbreviations

APIs:

Active pharmaceutical ingredients

BoI:

Board of investment

DRAP:

Drug regulatory authority of Pakistan

FDGs:

Focus group discussions

FDI:

Foreign direct investment

GDP:

Gross domestic product

GoP:

Government of Pakistan

HS Classification:

Harmonised system of classification

IBM:

Institute of Business Management

INR:

Indian rupee

ITC:

International trade centre

MFN:

Most favoured nation

MNCs:

Multi-national companies

MoC:

Ministry of Commerce, Pakistan

n.e.s:

Not elsewhere specified

NHSRC:

National Health Services Regulation and Coordination Division

OICCI:

Overseas Investors Chamber of Commerce and Industry

PKR:

Pakistani rupee

PPA:

Pakistan Pharmacist Association

PPMA:

Pakistan Pharmaceutical Manufacturers Association

QC:

Quality control

R&D:

Research and development

RCA:

Revealed comparative advantage

SMEDA:

Small and Medium Enterprise Development Authority

TDAP:

Trade Development Authority of Pakistan

References

  • Aamir, M., & Zaman, K. (2011). Review of Pakistan pharmaceutical industry: SWOT analysis. International Journal of Business and Information Technology, 1(1)

    Google Scholar 

  • Ahmed, M. (2012a). Trade of industrial goods with india: Opportunities and challenges for Pakistan. In Trade Development Authority of Pakistan.

    Google Scholar 

  • Ahmed, S. I. (2012b). Breaking the trade barrier. Himal South-Asian. (online) Available at: http://www.himalmag.com/component/content/article/5031-.html. Accessed on November 23, 2013.

  • Ahmed, V., Batool, S., & Khan, S. (2013a). Pharmaceutical trade with India. India-Pakistan trade Newsletter. December 2013. In Indian council for research on international economic relations.

    Google Scholar 

  • Ahmed, V., Batool, S., & Bhatti, U. (2013b). Pakistan’s trade with India: Case of auto sector in Pakistan. India-Pakistan trade Newsletter. January 2014. In Indian council for research on international economic relations.

    Google Scholar 

  • Ahmed, V., Suleri, A., Wahab, A., & Javed, A. (2013c). Informal flow of merchandise from India: The case of Pakistan. New Delhi: SDPI Working Paper.

    Google Scholar 

  • Alesina, A., Spolaore, E., & Wacziarg, R. (2005). Trade, growth and the size of countries. In Handbook of economic growth (Vol. 1). Elsevier. Amsterdam: North Holland.

    Google Scholar 

  • Balassa, B. (1965). Trade liberalisation and revealed comparative advantage. The Manchester School, 33(2:2), 99–123

    Google Scholar 

  • Batra, A., & Khan, Z. (2005). Revealed comparative advantage: An analysis for India and China. In ICRIER, India. Working Paper no. 168.

    Google Scholar 

  • Board of Investment. (2012). Pakistan investment guide 2012. Government of Pakistan.

    Google Scholar 

  • Business Monitor International. (2010). Pakistan pharmaceutical and health care report Q3 2010.

    Google Scholar 

  • Carsten, K. (2000). Welfare and integration. International Economic Review, 41(2).

    Google Scholar 

  • Chatterjee, B., & George, J. (2013). Reforming non-tariff barriers: Case for a participatory approach in South Asia. In Consumer unity and trust society (July 2013, pp. 132–138). India, Jaipur.

    Google Scholar 

  • HEC. (2010–11). Annual Report. Government of Pakistan.

    Google Scholar 

  • Hussain, I. (2011). Prospects and challenges for increasing India-Pakistan trade. Atlantic Council.

    Google Scholar 

  • India–Pakistan Trade. (2013). Website. Accessed on: September 16, 2013.

    Google Scholar 

  • Institute of Business Management. (2013). Pakistan business review 2013. Journal of Economic Literature, 14(4).

    Google Scholar 

  • International Trade Centre. (2013). Trade map.

    Google Scholar 

  • Lillah, W. (2012). MNCs have 53 % share in pharmaceutical market: National Assembly panel informed. Business Recorder. (online) Available at: http://www.brecorder.com/business-a-economy/189/1243095/. Accessed on: September 16, 2013.

  • Ministry of Commerce. (2013a). Website. In Government of Pakistan. Accessed on December 15, 2013.

    Google Scholar 

  • Ministry of Commerce, Pakistan. (2013b). Website. Accessed on: October 7, 2103 http://www.commerce.gov.pk/

  • Mishra, A. R. (2013). SAFTA members propose to reduce sensitive list. Live mint. (online) Available at: http://www.livemint.com/Politics/fInJz4wPhBeWZd0WBGz2bO/Safta-members-propose-to-reduce-sensitive-list.html. Accessed on: September 11, 2013.

  • Overseas Investors Chamber of Commerce and Industry. (2011). Annual report 2011.

    Google Scholar 

  • Picazo, O. (2011). Review of the Cheaper Medicines Program of Philippines, Philippines Institute of Development Studies.

    Google Scholar 

  • Qamar, A. (2005). Trade between India and Pakistan: Potential items and the MFN status. State Bank of Pakistan Research Bulletin, 1(1).

    Google Scholar 

  • SAARC Secretariat. (2013). Website. http://saarc-sec.org/areaofcooperation/detail.php?activity_id=35. Accessed on December 15, 2013.

  • Shahrukh, N. (2011). Pharmaceutical Industry Walking a Tightrope. In Weekly pulse. (online) Available at: http://weeklypulse.org/details.aspx?contentID=231&storylist=12. Accessed on: October 12, 2013.

  • State Bank of Pakistan. (2014). Pakistan custom tariff. http://www.sbp.org.pk/fe_returns/custom-tariff-07-08.pdf. Accessed on: February 16, 2014.

  • Taneja, N. (2013a). Additional trade challenges: Transport, transit, and non-tariff barriers. In M. Kugelman & R. Hathaway (Eds.,) Pakistan-India Trade: What Needs To Be Done? What Does It Matter? Woodrow Wilson International Center.

    Google Scholar 

  • Taneja, N. (2013b). What’s in it for us? The potential of India Pakistan trade. In Foreign policy. (online) Available at: http://afpak.foreignpolicy.com/posts/2013/04/15/whats_in_it_for_us_the_potential_in_india_pakistan_trade_0. Accessed on October 14, 2013.

  • Taneja, N., Mehra, M., Mukharjee, M., Bimal, S., & Dayal, I. (2013). Normalizing Normalising India Pakistan Trade. In Indian council for research on international economic relations. Working Paper no. 267.

    Google Scholar 

  • Times of Pakistan. (2011). Drug pricing policy-2011 finalized for approval to rationalize medicine prices. (online) Available at: http://timesofpakistan.pk/pakistan/2011-01-31/drugs-pricing-policy-2011-finalized-for-approval-to-rationalise-medicines-prices/23180/. Accessed on October 14, 2013.

  • Wajid, M. A. (2003). Trade with India in Pakistan’s Interest. In The Nation. (online). Accessed on October 14, 2013.

    Google Scholar 

  • Zaidi, S., Bigdeli, M., Aleem, N., & Rashidian, A. (2013). Access to essential medicines in Pakistan: Policy and health systems research concerns. PLoS One, 8(1).

    Google Scholar 

Download references

Disclaimer

Opinions and recommendations in the paper are exclusively of the author(s) and not of any other individual or institution including ICRIER.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vaqar Ahmed .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Indian Council for Research on International Economic Relations

About this chapter

Cite this chapter

Ahmed, V., Batool, S. (2017). India–Pakistan Trade: A Case Study of the Pharmaceutical Sector. In: Taneja, N., Dayal, I. (eds) India-Pakistan Trade Normalisation. Springer, Singapore. https://doi.org/10.1007/978-981-10-2215-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-2215-9_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-2214-2

  • Online ISBN: 978-981-10-2215-9

  • eBook Packages: Economics and FinanceEconomics and Finance (R0)

Publish with us

Policies and ethics